NANCY SHINA: Open Payments
NPI 1255884037 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 59 payments from 12 companies in 2025. Trend: 2023 $595 · 2024 $1,323 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $240 |
| Novartis Pharmaceuticals Corporation | 16 | $238 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $126 |
| Janssen Biotech, Inc. | 5 | $112 |
| Biofrontera Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Organon LLC | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| UCB, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $21 |
Products named: COSENTYX, SKYRIZI, ILUMYA, TREMFYA, RINVOQ, LIBTAYO, AMELUZ, NEMLUVIO.
Industry payments across UT — which companies pay providers there.
